Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard Masaru Kawamoto is active.

Publication


Featured researches published by Richard Masaru Kawamoto.


Journal of the American Society for Mass Spectrometry | 2006

MALDI-TOF MS as a label-free approach to rapid inhibitor screening

Kenneth D. Greis; Songtao Zhou; Thomas M. Burt; Andrew N. Carr; Elizabeth Dolan; Vijayasurian Easwaran; Artem G. Evdokimov; Richard Masaru Kawamoto; Jeff T. Roesgen; Gregory F. Davis

Mass Spectrometry (MS) has been widely reported for measuring the conversion of substrates to products for enzyme assays. These measurements are typically performed by time-consuming LC-MS to eliminate buffer salts that interfere with electrospray ionization MS. However, matrix-assisted laser desorption ionization, time-of-flight MS (MALDI-TOF MS) offers a label-free and direct readout of substrate and product, a fast sampling rate, and is tolerant of many buffer salts, reagents, and compounds that are typically found in enzyme reaction mixtures. In this report, a demonstration of how MALDI-TOF MS can be used to directly measure ratios of substrates and products to produce IC50 curves for rapid enzyme assays and compound screening is provided. Typical reproducibility parameters were <7% RSD—a value comparable to ESI MS quantitative assays and well within the acceptable limits for screening assays. The speed of the MALDI readout is currently about 10 s per sample, thus allowing for over 7500 samples/day. From a simplicity standpoint, the enzymatic reaction mixtures are prepared by liquid handling robots, the reactions are stopped by addition of a 10 times volume of acidic matrix solution, and the samples are simultaneously transferred to MALDI target plate for analysis. Importantly, the ratios of substrate to product are of sufficient reproducibility to eliminate the need for internal standards and, thus, minimize the cost and increasing the speed of assay development.


Bioorganic & Medicinal Chemistry Letters | 2000

Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitors

Benjamin E. Blass; C.T. Huang; Richard Masaru Kawamoto; Min Li; Song Liu; David E. Portlock; William Martin Rennells; Melanie Simmons

A series of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines was prepared using solution-phase, parallel synthesis and evaluated for Na+/K+ ATPase inhibition.


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors

Namal Chithranga Warshakoon; Shengde Wu; Angelique Sun Boyer; Richard Masaru Kawamoto; Sean Michael Renock; Kevin Xu; Matthew Pokross; Artem G. Evdokimov; Songtao Zhou; Carol Winter; Richard Walter; Marlene Mekel


Bioorganic & Medicinal Chemistry Letters | 2006

A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors

Namal Chithranga Warshakoon; Shengde Wu; Angelique Sun Boyer; Richard Masaru Kawamoto; Justin Sheville; Sean Michael Renock; Kevin Xu; Matthew Pokross; Artem G. Evdokimov; Richard Walter; Marlene Mekel


Bioorganic & Medicinal Chemistry Letters | 2006

Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors

Namal Chithranga Warshakoon; Shengde Wu; Angelique Sun Boyer; Richard Masaru Kawamoto; Justin Sheville; Sean Michael Renock; Kevin Xu; Matthew Pokross; Songtao Zhou; Carol Winter; Richard Walter; Marlene Mekel; Artem G. Evdokimov


Archive | 2007

Prolyl hydroxylase inhibitors and methods of use

Richard Masaru Kawamoto; Shengde Wu; Namal Chithranga Warshakoon; Artem G. Evdokimov; Kenneth D. Greis; Angelique Sun Boyer


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors

Namal Chithranga Warshakoon; Shengde Wu; Angelique Sun Boyer; Richard Masaru Kawamoto; Justin Sheville; Ritu Tiku Bhatt; Sean Michael Renock; Kevin Xu; Matthew Pokross; Songtao Zhou; Richard Walter; Marlene Mekel; Artem G. Evdokimov; Stephen Peter East


Archive | 2002

Medicinal uses of hydrazones

Ji-In Kim Almstead; Nicholas John Izzo; David Robert Jones; Richard Masaru Kawamoto


Archive | 2002

Medicinal uses of dihydropyrazoles

Ji-In Kim Almstead; Nicholas John Izzo; David Robert Jones; Richard Masaru Kawamoto


Archive | 2011

CRYSTAL OF HYPOXIA INDUCIBLE FACTOR 1 ALPHA PROLYL HYDROXYLASE

Artem G. Evdokimov; Richard Masaru Kawamoto; Angelique Sun Boyer; Marlene Mekel; Matthew Pokross; Richard Walter

Collaboration


Dive into the Richard Masaru Kawamoto's collaboration.

Researchain Logo
Decentralizing Knowledge